Research and development activities and R&D expenses
First written in FY2017-Q2. . Latest entry: FY2026.
90 other companies' latest entry also says "Other".
- FY2026Increase in annual R&D expensesAnnual report
「The Group's total R&D expenses for the consolidated fiscal year were ¥47 million.」
Annual R&D expenses amounted to ¥47 million, up from ¥39 million in the previous full-year disclosure. Research activities involving breeding technology, feed, quality, new products and other areas continued. - FY2026-H1Increase in interim R&D expensesAnnual report
「The Group's R&D expenses for the interim consolidated accounting period amounted to ¥26 million.」
Interim R&D expenses increased from ¥18 million in the same period of the previous year to ¥26 million. No material changes in the status of R&D activities were reported. - FY2025-H1Decline in interim R&D expensesAnnual report
「The Group's R&D expenses for the interim consolidated accounting period amounted to ¥18 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」
While there were no material changes in the status of R&D activities, interim R&D expenses amounted to ¥18 million, down from ¥66 million in the same period of the previous year. - FY2024Annual R&D expenses decreasedAnnual report
「The Group's total R&D expenses for the consolidated fiscal year were ¥119 million.」
Annual R&D expenses decreased from ¥124 million in the previous fiscal year to ¥119 million. Meanwhile, research activities involving breeding technology, feed, quality, new products and other areas continued. - FY2024-Q3Decrease in R&D expenses year on yearAnnual report
「Group-wide research and development expenses for the nine-month period of the third quarter of the current consolidated fiscal year amounted to ¥88 million.」
R&D expenses amounted to ¥88 million, down from ¥95 million in the same period of the previous year. No material changes in the status of R&D activities were reported. - FY2024-Q2Decrease in R&D expenses year on yearAnnual report
「The Group's R&D expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥58 million.」
R&D expenses amounted to ¥58 million, down from ¥66 million in the same period of the previous year. No material changes in the status of R&D activities were reported. - FY2024-Q1Year-on-year decrease in cumulative quarterly R&D expensesAnnual report
「The Group's R&D expenses for the cumulative first quarter of the current consolidated fiscal year amounted to ¥29 million.」
Cumulative quarterly R&D expenses amounted to ¥29 million, down ¥1 million from ¥30 million in the same period of the previous year. No material changes in the status of R&D activities were reported. - FY2023Increase in annual R&D expensesAnnual report
「The Group's total R&D expenses for the consolidated fiscal year were ¥124 million.」
Annual R&D expenses amounted to ¥124 million, up from ¥117 million in the previous fiscal year. Research activities involving breeding technology, feed, quality, new products and other areas continued. - FY2023-Q3Increase in R&D expenses year on yearAnnual report
「The Group's R&D expenses for the cumulative third quarter of the current consolidated fiscal year amounted to ¥95 million.」
R&D expenses amounted to ¥95 million, up from ¥85 million in the same period of the previous year. No material changes in the status of R&D activities were reported. - FY2023-Q2Increase in R&D expenses year on yearAnnual report
「The Group's R&D expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥66 million.」
R&D expenses amounted to ¥66 million, up from ¥58 million in the same period of the previous year. No material changes in the status of R&D activities were reported. - FY2023-Q1Increase in R&D expenses year on yearAnnual report
「The Group's R&D expenses for the cumulative first quarter of the current consolidated fiscal year amounted to ¥30 million.」
R&D expenses amounted to ¥30 million, up from ¥26 million in the same period of the previous year. No material changes in the status of R&D activities were reported. - FY2022-Q3Decrease in R&D expenses year on yearAnnual report
「The Group's R&D expenses for the cumulative third quarter of the current consolidated fiscal year amounted to ¥85 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
While there were no material changes in R&D activities, R&D expenses amounted to ¥85 million, down from ¥87 million in the same period of the previous year. - FY2022-Q2Decrease in R&D expenses year on yearAnnual report
「The Group's R&D expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥58 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
While there were no material changes in R&D activities, R&D expenses amounted to ¥58 million, down from ¥65 million in the same period of the previous year. - FY2022-Q1Quarterly R&D expenses in line with the same period of the previous yearAnnual report
「The Group's R&D expenses for the cumulative first quarter of the current consolidated fiscal year amounted to ¥26 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥26 million, the same as in the same period of the previous year. No material changes in the status of R&D activities were reported. - FY2021Slight increase in annual R&D expensesAnnual report
「The Group's total R&D expenses for the consolidated fiscal year were ¥119 million.」
Annual R&D expenses amounted to ¥119 million, up from ¥116 million in the previous consolidated fiscal year. Research activities involving breeding technology, feed, quality, new products, environmental conditions and other areas continued. - FY2021-Q3Slight year-on-year decrease in R&D expensesAnnual report
「The Group's R&D expenses for the cumulative third quarter of the current consolidated fiscal year amounted to ¥87 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
While there were no material changes in R&D activities, R&D expenses amounted to ¥87 million, a slight decrease from ¥88 million in the same period of the previous year. - FY2021-Q2Decrease in R&D expenses year on yearAnnual report
「The Group's R&D expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥62 million.」
While there were no material changes in the status of R&D activities, R&D expenses amounted to ¥62 million, down from ¥65 million in the same period of the previous year. - FY2021-Q1Increase in R&D expenses year on yearAnnual report
「The Group's R&D expenses for the cumulative first quarter of the current consolidated fiscal year amounted to ¥33 million.」
R&D expenses were ¥33 million, up from ¥26 million in the same period of the previous year. No material changes in the status of R&D activities were reported. - FY2020-Q3Slight year-on-year decrease in R&D expensesAnnual report
「The Group's R&D expenses for the cumulative third quarter of the current consolidated fiscal year amounted to ¥87 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenses were ¥87 million, a slight decrease from ¥88 million in the same period of the previous year. No material changes in the status of R&D activities were reported. - FY2020-Q2Decrease in R&D expenses year on yearAnnual report
「The Group's R&D expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥56 million.」
R&D expenses were ¥56 million, down from ¥65 million in the same period of the previous year. No material changes in the status of R&D activities were reported. - FY2020-Q1Increase in cumulative quarterly research and development expensesAnnual report
「The Group's R&D expenses for the cumulative first quarter of the current consolidated fiscal year amounted to ¥28 million.」
R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥28 million, up from ¥26 million in the same period of the previous year. No material changes in the status of R&D activities were reported. - FY2019Annual R&D expenses decreasedAnnual report
「The Group's total R&D expenses for the consolidated fiscal year were ¥102 million.」
Annual R&D expenses were ¥102 million, down from ¥115 million in the previous fiscal year. Research activities involving breeding technology, feed, quality, new products, environmental control equipment and other areas continued. - FY2019-Q3Decrease in R&D expenses year on yearAnnual report
「The Group's R&D expenses for the cumulative third quarter of the current consolidated fiscal year amounted to ¥77 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenses of ¥77 million were disclosed, while no material changes in R&D activities were reported. The amount was down from ¥88 million in the same period of the previous year. - FY2019-Q2Decrease in R&D expenses year on yearAnnual report
「The Group's R&D expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥53 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenses of ¥53 million were disclosed for the cumulative second quarter of the current consolidated fiscal year, while no material changes in R&D activities were reported. The amount was down from ¥65 million in the same period of the previous year. - FY2019-Q1Decrease in cumulative quarterly R&D expensesAnnual report
「The Group's R&D expenses for the cumulative first quarter of the current consolidated fiscal year amounted to ¥26 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
Cumulative quarterly R&D expenses were ¥26 million, down from ¥32 million in the same period of the previous year. No material changes in the status of R&D activities were reported. - FY2018Disclosure of annual R&D expensesAnnual report
「The Group's total R&D expenses for the consolidated fiscal year were ¥115 million.」
Annual R&D expenses of ¥115 million were disclosed, along with specific explanations of R&D activities involving breeding technology, feed, quality, new products, environmental control equipment and other areas. - FY2018-Q3Increase in cumulative quarterly research and development expensesAnnual report
「Group-wide research and development expenses for the nine-month period of the third quarter of the current consolidated fiscal year amounted to ¥88 million.」
Cumulative quarterly research and development expenses increased from ¥65 million in the previous quarter to ¥88 million. The company stated that there had been no material change in the status of research and development activities. - FY2018-Q2Increase in cumulative quarterly research and development expensesAnnual report
「The Group's total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥65 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
The company disclosed ¥65 million in cumulative quarterly research and development expenses while stating that there had been no material change in research and development activities. - FY2018-Q1Disclosure of cumulative quarterly research and development expensesAnnual report
「Group-wide research and development expenses for the three-month period of the first quarter of the current consolidated fiscal year amounted to ¥32 million. There was no material change in the status of the group’s research and development activities during the three-month period of the first quarter of the current consolidated fiscal year.」
Research and development expenses of ¥32 million for the three-month period of the first quarter of the current consolidated fiscal year have been disclosed, with no material change in the status of research and development activities reported. - FY2017-Q3Increase in R&D expensesAnnual report
「Group-wide research and development expenses for the nine-month period of the third quarter of the current consolidated fiscal year amounted to ¥79 million.」
Research and development expenses increased from ¥54 million in the previous quarter to ¥79 million. There was reportedly no material change in the status of research and development activities. - FY2017-Q2First statedAnnual report
「Group-wide research and development expenses for the nine-month period of the current consolidated fiscal year amounted to ¥54 million.」
Group-wide research and development expenses of ¥54 million for the nine-month period of the current consolidated fiscal year have been disclosed.